We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

DB function failed with error number 0

Advanced Endoscopy Platform Recognized for Third Space Procedures

More...
13 May 2026
Image: The platform is built on a foundation model of tumor and immune biology, integrating genomic, transcriptomic, immune, and clinical signals to generate biologically grounded insights (image credit: 123RF)

AI-Driven Tumor Profiling Initiative Targets Precision Therapy Development

An AI platform integrates DNA/RNA and immune profiling to guide treatment selection across more than 20 cancer types. More...
12 May 2026
Image: The fully automated workflow builds on growing adoption of LIAISON QuantiFERON‑TB Gold Plus II (photo courtesy of Diasorin)

Automated Workflow and AI Tool Enhance Latent TB Testing and Risk Stratification

A fully automated workflow for latent TB screening combines the QuantiFERON test, DiaSorin LIAISON systems, and Inpeco end-to-end automation. More...
10 May 2026
Image:The transaction is expected to close in the second half of 2026, with Roche paying USD 750 million upfront and up to USD 300 million in additional milestone payments

Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio

Roche entered an agreement to acquire PathAI for up to $1.05 billion, strengthening the AI capabilities of its Diagnostics division More...
08 May 2026
Image: The approval enables clinical laboratories to use a validated, blood-based method to determine eligibility for the targeted therapy (photo courtesy of Guardant Health)

FDA Clears Blood-Based Companion Diagnostic for Advanced Breast Cancer Therapy

A new FDA-approved liquid biopsy identifies ESR1 mutations to guide vepdegestrant use in ER+/HER2- advanced breast cancer. More...
06 May 2026
Image: CareDx entered an agreement to acquire Naveris for $160 million upfront, with up to $100 million in additional milestone payments.

CareDx Expands Precision Oncology Portfolio with Naveris Acquisition

CareDx entered an agreement to acquire Naveris for $160 million upfront, with up to $100 million in additional milestone payments. More...
29 Apr 2026
Image: Thermo Fisher expects the transaction with Astorg to close in the second half of 2026

Thermo Fisher Scientific to Sell Microbiology Business to Astorg

Thermo Fisher's microbiology portfolio of AST and culture media solutions has been acquired by Astorg. More...
29 Apr 2026
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
New
Immunofluorescence Analyzer
IFA System
New
Urine Analyzer
respons® UDS100


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
ADLM